Header
PUBLICATIONS AND REPORTS
 
Search Website
GO
Publications
 
INTERIM RESULTS FROM THE CATNON TRIAL (EORTC STUDY 26053-22054) OF TREATMENT WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE FOR 1P/19Q NON-CO-DELETED ANAPLASTIC GLIOMA: A PHASE 3, RANDOMISED, OPEN-LABEL INTERGROUP STUDY
Martin J van den Bent, Brigitta Baumert, Sara C Erridge, Michael A Vogelbaum, Anna K Nowak, Marc Sanson, Alba Ariela Brandes, Paul M Clement, Jean Francais Baurain, Warren P Mason, Helen Wheeler, Olivier L Chinot, Sanjeev Gill, Matthew Griffin, David G Brachman, Walter Taal, Roberta Rudà, Michael Weller, Catherine McBain, Jaap Reijneveld, Roelien H Enting, Damien C Weber, Thierry Lesimple, Susan Clenton, Anja Gijtenbeek, Sarah Pascoe, Ulrich Herrlinger, Peter Hau, Frederic Dhermain, Irene van Heuvel, Roger Stupp, Ken Aldape, Robert B Jenkins, Hendrikus Jan Dubbink, Winand N M Dinjens, Pieter Wesseling, Sarah Nuyens, Vassilis Golfinopoulos, Thierry Gorlia, Wolfgang Wick, Johan M Kros. Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. The Lancet. Published online 8 August 2017. Article available on http://dx.doi.org/10.1016/S0140-6736(17)31442-3
 
THE ROLE OF EARLY MRI IN PREDICTING SURVIVAL WHILE ON BEVACIZUMAB IN RECURRENT GLIOBLASTOMA: RESULTS FROM A PROSPECTIVE CLINICAL TRIAL (CABARET)
Field KM, Phal PM, Fitt G, Goh C, Nowak AK, Rosenthal MA, Simes J, Barnes EH, Sawkins K, Cher LM, Hovey EJ, Wheeler H. The role of early MRI in predicting survival while on bevacizumab in recurrent glioblastoma: results from a prospective clinical trial (CABARET). Cancer. Published online 5 June 2017. Article available on http://dx.doi.org/10.1002/cncr.30838

CONTINUING OR CEASING BEVACIZUMAB BEYOND PROGRESSION IN RECURRENT GLIOBLASTOMA: AN EXPLORATORY RANDOMIZED PHASE II TRIAL
Elizabeth J Hovey, Kathryn M Field, Mark A Rosenthal, Elizabeth H Barnes, Lawrence Cher, Anna K Nowak, Helen Wheeler, Kate Sawkins, Ann Livingstone, Pramit Phal, Christine Goh, John Simes, on behalf of CABARET/COGNO investigators. Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: an exploratory randomized phase II trial. Neuro-Oncology Practice. Published online 25 May 2017. Article available on  https://doi.org/10.1093/nop/npw025
  
HEALTH-RELATED QUALITY OF LIFE OUTCOMES FROM CABARET: A RANDOMIZED PHASE 2 TRIAL OF CARBOPLATIN AND BEVACIZUMAB IN RECURRENT GLIOBLASTOMA
Kathryn M. Field, Madeleine T. King, John Simes, David Espinoza, Elizabeth H. Barnes, Kate Sawkins, Mark A. Rosenthal, Lawrence Cher, Elizabeth Hovey, Helen Wheeler, Anna K. Nowak. Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma. Journal of Neuro-Oncology. Published online 22 May 2017. Article available on http://dx.doi.org/10.1007/s11060-017-2479-8
 
VELIPARIB IN COMBINATION WITH RADIOTHERAPY FOR THE TREATMENT OF MGMT UNMETHYLATED GLIOBLASTOMA (PRE-CLINICAL WORK FOR VERTU)
Jue TR, Nozue K, Lester AJ, Joshi S, Schroder LB, Whittaker SP, Nixdorf S, Rapkins RW, Khasraw M, McDonald KL. Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma (pre-clinical work for VERTU). Journal of Translational Medicine. Published online 17 March 2017. Article available on http://dx.doi.org/10.1186/s12967-017-1164-1
 
EARLY PERFUSION MRI PREDICTS SURVIVAL OUTCOME IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED WITH BEVACIZUMAB AND CARBOPLATIN
Bennett IE, Field KM, Hovens CM, Moffat BA, Rosenthal MA, Drummond K, Kaye AH, Morokoff AP. Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin. Journal of Neuro-Oncology. Published online 28 November 2016. Article available on https://doi.org/10.1007/s11060-016-2300-0

COMBINING PARP INHIBITORS WITH RADIATION THERAPY FOR THE TREATMENT OF GLIOBLASTOMA: IS PTEN PREDICTIVE OF RESPONSE? (PRE-CLINICAL WORK FOR VERTU)
Lester A, Rapkins R, Nixdorf S, Khasraw M, McDonald K. Combining PARP inhibitors with radiation therapy for the treatment of glioblastoma: Is PTEN predictive of response? (pre-clinical work for VERTU). Clinical and Translational Oncology. Published online 21 September 2016. Article available on http://dx.doi.org/10.1007/s12094-016-1547-4

EVOLVING MANAGEMENT OF LOW GRADE GLIOMA: NO CONSENSUS AMONGST TREATING CLINICIANS
KM Field, MA Rosenthal, M Khasraw, K Sawkins, AK Nowak. Evolving Management of Low Grade Glioma: No Consensus Amongst Treating Clinicians. Journal of Clinical Neuroscience. Published online January 2016. Article available on https://doi.org/10.1016/j.jocn.2015.05.038

IMPACT OF COGNITIVE FUNCTION ON COMMUNICATION IN PATIENTS WITH PRIMARY OR SECONDARY BRAIN TUMOURS (COGNO ENDORSED STUDY)
Diana N. Naehrig, Eng-Siew Koh, Monica Vogiatzis, Waka Yanagisawa, Carol Kwong, Heather L. Shepherd, Chris Milross, Haryana M. Dhillon. Impact of cognitive function on communication in patients with primary or secondary brain tumours. Journal of Neuro-Oncology. Published online 26 October 2015. Article available on http://link.springer.com/article/10.1007%2Fs11060-015-1964-1

VALIDATING SELF-REPORT AND PROXY REPORTS OF THE DEXAMETHASONE SYMPTOM QUESTIONNAIRE -CHRONIC FOR THE EVALUATION OF LONGER-TERM CORTICOSTEROID TOXICITY
Meera Agar, Eng-Siew Koh, Emma Gibbs, Elizabeth H. Barnes, Elizabeth Hovey, Ann Livingstone, Kate Sawkins, Richard Chye, Melanie R. Lovell, Katherine Clark, Janette Vardy, Madeleine King, On behalf of the Cooperative Trials Group for Neuro-Oncology (COGNO). Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire -Chronic for the evaluation of longer-term corticosteroid toxicity. Supportive Care in Cancer. Published online 21 August 2015. Article available on http://link.springer.com/article/10.1007/s00520-015-2897-0

RANDOMIZED PHASE 2 STUDY OF CARBOPLATIN AND BEVACIZUMAB IN RECURRENT GLIOBLASTOMA
Kathryn M. Field, John Simes, Anna K. Nowak, Lawrence Cher, Helen Wheeler, Elizabeth J. Hovey, Christopher S.B. Brown, Elizabeth H. Barnes, Kate Sawkins, Ann Livingstone, Ron Freilich, Pramit M. Phal, Greg Fitt, CABARET/COGNO investigators and Mark A. Rosenthal. Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma. Neuro-Oncology. Published online 30 June 2015. Article available on https://doi.org/10.1093/neuonc/nov104

PATTERNS OF CARE IN ADULT MEDULLOBLASTOMA
Cosman R, Brown CSB, DeBraganca KC, Khasraw M, for the Cooperative Trials Group for Neuro-Oncology (COGNO). Patterns of care in adult medulloblastoma: results of an international online survey. Journal of Neuro-Oncology. 16 July 2014 Epub ahead of print. Article available on http://link.springer.com/article/10.1007/s11060-014-1525-z

CULTURALLY AND LINGUISTICALLY DIVERSE PATIENT PARTICIPATION IN GLIOMA RESEARCH

Lwin Z, Broom A, Cosman R, Livingstone A, Sawkins K, Good P, Kirby E, Koh ES and Hovey E on behalf of the COGNO CALD working group. Culturally and linguistically diverse patient participation in glioma research. Neuro-Oncology Practice. 25 June 2014 Epub ahead of print. Article available on http://dx.doi.org/10.1093/nop/npu009

NEURO-ONCOLOGY PRACTICES IN AUSTRALIA
Chen JY, Hovey E, Rosenthal M, Livingstone A, Simes J, for the Cooperative Trials Group for Neuro-Oncology (COGNO). Neuro-Oncology practices in Australia: A Cooperative Group for Neuro-Oncology patterns of care study. Asia-pacific Journal of Clinical Oncology. 29 May 2013 Epub ahead of print. Article available on http://dx.doi.org/10.1111/ajco.12079

GLIOBLASTOMA MULTIFORME
Ananda S, Nowak AK, Cher L, Dowling A, Brown C, Simes J, Rosenthal MA, for the Cooperative Trials Group for Neuro-Oncology (COGNO). Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy. Journal of Clinical Neuroscience. Published online 2 August 2011. Article available on https://linkinghub.elsevier.com/retrieve/pii/S0967-5868(11)00222-0
 

Reports
 
2010 COGNO PATTERNS OF CARE STUDY IN NEURO-ONCOLOGY IN AUSTRALIA
Chen JY, Hovey E, Rosenthal M, Livingstone A, Simes J. Report available here: 2010 COGNO Patterns of Care Study in Neuro-oncology in Australia.